ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced a strategic collaboration with Labcorp ...
Add Yahoo as a preferred source to see more of our stories on Google. A pedestrian walks by a LabCorp office on February 11, 2021, in Greenbrae, California. Labcorp has made the colorectal cancer ...
Colorectal cancer is highly preventable when detected early, yet approximately 4 in 10 eligible adults are not up to date with recommended screenings. While at-home tests offer convenience, the ...
Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...
Diagnostics giant Labcorp has introduced Test Finder, a generative AI tool developed in conjunction with Amazon Web Services (AWS). Test Finder aims to simplify lab test selection by permitting ...
A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...
Pixel by Labcorp is a service offering various at-home and in-person tests for different health conditions. The tests come with step-by-step instructions, and the company works with independent ...
WASHINGTON (AP) — In a story March 24 about colon cancer screening tests, The Associated Press reported erroneously that the Colosure test from LabCorp is approved by the Food and Drug Administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results